Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteScienzaWeb e Social Network

44 comunicati stampa

Guarda tutti i comunicati
03/06/2026
Eventi
Web e Social Network
Biotecnologia
Scienza
Salute
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
02/06/2026
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
08/05/2026
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
06/05/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
04/05/2026
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
28/04/2026
Mercato del lavoro
Industria
Salute
Scienza
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
22/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Comunicazione
Scienza
Sanità
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
09/04/2026
Mercato del lavoro
Industria
Salute
Fitness
Scienza
Farmaceutica
Biotecnologia
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
31/03/2026
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
19/03/2026
Finanza
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience Increases Share Repurchase Program to $20 Million
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0